Amgen to Increase Dividend; Share Buy Backs (AMGN)

Biotechnology medicines company, Amgen, Inc.(AMGN) reported on Friday a plan to increase dividend payouts, and issue share buy backs in early 2013.

The company reported a plan to increase dividend payments by 31% to 47 cents per share during the first quarter of 2013. AMGN, which is the only biotechnology company to pay a dividend, currently pays a quarterly dividend of 36 cents per share. Analysts expected the company to raise dividends to 40 cents per share.

In addition to a dividend increase, the company announced a plan to buy back $2 billion in shares during the first quarter of 2013. This buy back program is expected to continue to become a $10 billion program.

Seeking new acquisitions to increase revenues, the company reported a plan to purchase DeCode Genetics Inc. which was approved for $415 million. Additionally, AMGN acquired Micromet Inc.(MITI) for $1.16 billion earlier this year.

Amgen shares were mostly flat during premarket trading Friday. The stock is up 38% YTD.

The Bottom Line
Shares of Amgen (AMGN) will now have a 2.11% dividend yield, based on the higher dividend payout and last night’s closing stock price of $89.15. The stock has technical support in the $82-$85 price area. The shares are trading near all-time highs.

Amgen, Inc.(AMGN) is not recommended at this time, holding a DARS™ Rating of
3.4 out of 5 stars.

Be sure to visit our complete recommended list of the Best Dividend Stocks, as well as a detailed explanation of our ratings system here.

Related Stocks:
Stock Market XML and JSON Data API provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays. Stock Market Holiday List
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Press Release Service provided by PRConnect.
Stock quotes supplied by Six Financial
Postage Rates Bots go here